Navigation Links
Zimmer Holdings to Present at Upcoming Investor Conferences
Date:9/1/2009

WARSAW, Ind., Sept. 1 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today it will be participating in the following investor conferences during the month of September:

  • Thomas Weisel Partners Healthcare Conference 2009 in Boston, Mass., on September 9, 2009, at 11:30 a.m. Eastern Time;
  • Morgan Stanley Healthcare Unplugged 2009 Conference in New York, N.Y., on September 14, 2009, at 8:35 a.m. Eastern Time; and
  • UBS Global Life Sciences Conference in New York, N.Y., on September 21, 2009, at 8:00 a.m. Eastern Time.

Live webcasts of the presentations can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. The webcasts will be archived for replay following the conferences.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit www.zimmer.com


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Zimmerman Travels Across Country for $10M Weight Loss
2. Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference
3. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
4. Zimmer Holdings to Present at Deutsche Bank 34th Annual Health Care Conference
5. Zimmer Holdings, Inc. Reports First Quarter 2009 Financial Results
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2009 Results
7. Zimmer Announces Expiration of Deferred Prosecution Agreement
8. Zimmer Holdings Names Marc Casper to Board of Directors
9. Nyer Medical Appoints Sandra Zimmerman as Chief Financial Officer
10. Zimmer Presents Trabecular Metal Technology Experience at AAOS Annual Meeting
11. Zimmer Reports Fourth Quarter and 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 18, 2017 , ... ... at creating a transparent, verifiable database to help the cannabis industry move towards ... Paragon hopes to deliver a faster technology with lower fees. Paragon will build ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has ... These illustrations show the diversity of the breastfeeding mothers, using bright colors ... of sizes. These illustrations are also available on tote bags, notepads, smartphone cases, ...
(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... York, New York (PRWEB) , ... ... ... International Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light ... announced it has entered into a definitive agreement to purchase Unitrans International ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/2/2017)... Calif. , Aug. 2, 2017 ... Continental Who,s Who as a Pinnacle Lifetime Professional ... the Key Account Manager at Turing Pharmaceuticals, AG. ... negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience as ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
Breaking Medicine Technology: